[ad_1]
The Food and Drug Administration has approved a new artificial intelligence-based X-ray machine that, according to GE Healthcare, reduces the time to diagnosis and treatment of a lung collapsed from eight hours to as little than 15 minutes, announced the company Thursday.
The device, called the Critical Care Suite, uses AI algorithms to scan x-ray images and detect a pneumothorax, a deadly disease more commonly known as a collapsed lung that affects approximately 74,000 Americans each year.
"The healthcare industry is producing huge amounts of image data from digital health records," GE Healthcare General Manager Kieran Murphy said in an interview with CNBC. . "We strongly believe that you need to turn this data into information and perspectives to improve results."
GE Healthcare, a leading player in hospital and laboratory equipment, said its goal was to integrate AI into all aspects of the healthcare system to "improve" patient outcomes, reduce waste and inefficiency, and eliminate costly mistakes ".
The General Electric unit technology, developed with a scientist from the University of California at San Francisco, is trained in the detection of pneumothorax, but the company said it was working at the company. to improve to detect other health problems.
The technology uses artificial intelligence to analyze the images of an x-ray, the company said. If a condition is suspected – in this case, a pneumothorax – the image is sent directly to the radiologist for examination. The technology works outside the cloud and does not depend on an internet connection, the company said.
"Currently, 62% of portable chest exams are marked" STAT "or for urgent reading, but not all are critical," said Jie Xue, president and chief executive officer of the firm's radiography division. "This creates a delay in the treatment of really critical patients, which can be a serious problem."
FDA approval comes at a time when the AI is expanding into the medical field, helping doctors quickly analyze a range of diseases and thereby reduce costs and inefficiencies. Although optimism is optimistic, technology is making important medical decisions.
"There is no suggestion that you replace the radiologist," Murphy said in the interview. "Naturally, [the radiologist] check that they agree with the conclusion. But so far, the accuracy of large pneumomothroax is 96% and a very low number of false; this is also a problem of course. "
The device is expected to hit the US market this year.
The health care unit has grown considerably since its origins in 1896, when it began to develop X-rays. The company has become a leader in the field of health care. It is already a major player in hospital and laboratory equipment and is a growing force in medical records, healthcare software and has expanded its brand on gene therapy research.
In February, GE announced plans to sell its biopharmaceutical share to the Danaher Industrial Corporation for $ 21.4 billion.
[ad_2]
Source link